Actual use of asthma medications contradicts guidelinesMarch 28, 2008A study has found only 16% of the 352,082 Australians who filled a prescription for asthma preventer medications for the first time during the period July 2004 to June 2005, went on to use them regularly. Most (61%) 'first time' users did not fill another prescription in the next two years while 22% did so sporadically. The research will be presented at the Thoracic Society of Australia and New Zealand (TSANZ) Conference which starts this Sunday in Melbourne.
The study was conducted by the Australian Centre for Asthma Monitoring, a collaborating unit of the Australian Institute of Health and Welfare based at the Woolcock Institute of Medical Research in Sydney. It analysed the anonymous Pharmaceutical Benefits Scheme (PBS) records of individuals who filled a prescription for preventer medications for asthma for the first time between July 2004 and June 2005, and their subsequent prescription activity over a period of two years. The most commonly used form of preventer medication is inhaled corticosteroids. Professor Guy Marks, Head of Epidemiology Research at the Woolcock Institute, said the results indicated that the prevalence of one-time and sporadic use was highest in young adults (age 15-34 years) with regular use most common in adults aged 65 years and over. "The PBS dataset is a valuable tool for assessing patterns of asthma medication use," he said. "Importantly this study shows that while guidelines recommend regular use of preventer medication, this certainly isn't happening in the community. At least some of those people who are now using preventer medication sporadically, could be expected to benefit from regular use of this class of medications. Research Australia | |||||||||||||||||||||
|
Related Asthma Medications Current Events and Asthma Medications News Articles Steroids Not as Effective in Obese Asthma Patients Researchers at National Jewish Health have shown that glucocorticoids, the primary controller medication for asthma, are 40 percent less effective in overweight and obese asthma patients than in those of normal weight. Note to pediatricians: Taper meds in kids with stable asthma A study of how pediatricians prescribe asthma medications suggests that while most would readily increase a child's medication if needed, many are reluctant to taper off drug use when less might be best. Pharmacists as educators can improve asthma outcomes New research has shown that up to 90 per cent of people on asthma medications are using their inhalers incorrectly leading to poor asthma control, increased hospital visits and increased cost of treatment. Girls and children exposed to tobacco smoke benefit more from montelukast (singulair) Girls and children exposed to tobacco smoke respond particularly well to montelukast (Singulair) according to researchers at National Jewish Medical and Research Center. 1-year results of bronchial thermoplasty in refractory asthma Asthmatx, Inc., a medical device company that has developed a catheter-based procedure under investigation for the treatment of asthma, announced today the publication of data from the Research in Severe Asthma (RISA) Trial of bronchial thermoplasty in the American Journal of Respiratory and Critical Care Medicine (AJRCCM, 2007; 176:1185-1191). Parents' perceptions can hamper kids' asthma care, study finds The next battle in the war on asthma symptom control could be a psychological one, a new study finds. Survey shows asthma not controlled in majority of patients A survey of 1,812 patients with moderate-to-severe asthma revealed that the disease was not controlled in 55 percent, despite the fact that most had health insurance and visited their health care providers regularly. 'Red tide toxins' leave beachgoers breathless The ecological phenomenon, known as Florida red tide, can be harmful for people with asthma. Florida red tides, an annual event in areas along the Gulf of Mexico, are blooms of the ocean organism, Karenia brevis (K brevis), that are concentrated along shorelines and produce highly potent aerosolized toxins. Research suggests beta agonists may alter the immune system New research at Wake Forest University School of Medicine suggests that certain inhaled asthma medications - as well as similar chemicals our bodies produce during times of high stress - may worsen diseases such as asthma, heart failure and lupus that involve inflammation. Experts add to growing warnings about asthma drug University of Iowa asthma experts are trying to ensure that an asthma drug combination is prescribed only when truly necessary. More Asthma Medications Current Events and Asthma Medications News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||